WESTPORT, CT⎯October 10, 2017⎯Connecticut Innovations, Benslie Limited, and Stonehenge Growth Capital announced today that they consummated an equity investment in Convexity Scientific Inc., a life sciences company committed to bringing the best user experience to patients through its innovative design and distribution strategies. Convexity’s business strategy leverages its unique ability to develop healthcare products with innovative design and superior ease-of-use. The company’s first product, a nebulizer for the treatment of asthma, COPD, and other respiratory diseases, is notable for its extremely small size, light weight, and simplicity. “We believe Convexity’s nebulizer is a game-changer,” said Benslie Partner Henry Weinstein. “It sets a new standard in the US and international markets and its distribution strategy is both unique and highly scalable.” “We are very excited about Convexity Scientific’s future and are delighted to partner with our new investors,” said Ralph Finger, MD, Convexity’s Chairman. “The deep experience in life sciences Connecticut Innovations and Stonehenge bring, together with Benslie’s global reach, create a formidable combination.”

About Convexity Scientific Inc.
Convexity Scientific Inc. is a life sciences company committed to bringing the best user experience to patients through its innovative design and distribution strategies. Its first medical device, a handheld nebulizer used to treat respiratory diseases, was recently cleared by FDA.

About Benslie Limited
Benslie is an investment vehicle of EMC2 Fund Ltd, which has several venture capital investments in the US and Israel.

About CT Innovations
Connecticut Innovations is Connecticut’s strategic venture capital arm, providing funding and strategic support to early-stage technology companies. In addition to equity investments, CI provides grants that support innovation and collaboration through CTNext, and connections to its well-established network of partners and professionals. To learn more, visit ctinnovations.com.

About Stonehenge Growth Capital
Stonehenge Growth Capital, a subsidiary of Stonehenge Capital Company LLC, provides venture capital, private equity and mezzanine debt to companies led by experienced management teams with a passion for innovation and the pursuit of high-growth opportunities. With a flexible and creative approach, the Growth Capital team develops customized financing solutions based on a company’s unique strategic and financial plans. The Growth Capital team has invested over $1.0 billion in small and medium-sized businesses across venture capital, private equity and debt funds since 1993. To learn more about Stonehenge Growth Capital, please visit stonehengecapital.com.